21 Dec 2017
10 highlights: A look back at 2017
With 2017 quickly coming to close, we’d like to reflect on all that’s been accomplished by rounding up some of this year’s...Read More
30 Nov 2017
Clinical trial investigates possible triple threat for lung cancer
A first-of-its-kind combination of medications may enable the immune system to better combat lung cancer, which claims more lives than any other...Read More
12 Oct 2017
A Catalyst for combating cancer
Nearly $5.5 million in grant funding to fuel collaborative clinical trials in lung and bladder cancers By Dr. Peter Jones and Dr....Read More
15 May 2017
Dr. Stephen Baylin becomes third VARI-affiliated scientist to be elected to National Academy of Sciences
VARI-affiliated cancer researcher Stephen Baylin, M.D., has been elected to the National Academy of Sciences (NAS). He is the third VARI-affiliated scientist...Read More
15 May 2017
3 Feb 2017
In their own words: The most exciting advances in cancer research
In honor of World Cancer Day on Saturday, we asked our scientists and collaborators a simple question—what do you think is the...Read More
10 Oct 2016
Combinations and collaborations in the fight against cancer: An interview with Dr. Feyruz Rassool and Dr. Stephen Baylin
What happens when scientists collaborate rather than compete? In this case, the result is a combination of two drugs that may be...Read More
29 Aug 2016
Vitamin C may boost effectiveness of acute myeloid leukemia treatment
EDITOR’S NOTE: Maintaining proper nutrition is an important part of cancer therapy. Patients are urged to consult their doctors before making any...Read More
28 Jan 2016
Phase II colorectal cancer clinical trial first to receive support, scientific oversight from Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team
GRAND RAPIDS, Mich. (Jan. 28, 2016)—The first clinical trial to move forward as part of the Van Andel Research Institute–Stand Up To...Read More